C07C 50/06
With unsaturation outside the quinoid structure
Official title: with unsaturation outside the quinoid structure
C07C50/06 (With unsaturation outside the quinoid structure) appears on 33 US grants and 26 published applications in this corpus.
Search patents in C07C- Granted patents
- 33
- Published applications
- 26
- Assignees
- 28
- Inventors
- 61
- Latest grant
- 16 Jul 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 2 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 4 |
| 2008 | 1 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 2 |
| 2011 | 0 | 0 |
| 2012 | 1 | 1 |
| 2013 | 1 | 2 |
| 2014 | 2 | 1 |
| 2015 | 1 | 1 |
| 2016 | 3 | 2 |
| 2017 | 1 | 1 |
| 2018 | 2 | 1 |
| 2019 | 1 | 1 |
| 2020 | 1 | 1 |
| 2021 | 2 | 3 |
| 2022 | 1 | 1 |
| 2023 | 0 | 1 |
| 2024 | 1 | 1 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Compositions and methods for the prevention and/or treatment of mitochondrial disease, including Friedreich's ataxia16 Jul 2024US 12,037,350 B2Stealth BioTherapeutics Inc.
- Deuterated EPI-7438 Mar 2022US 11,267,777 B2Concert Pharmaceuticals, Inc.
- Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers1 Jun 2021US 11,021,424 B2PTC Therapeutics, Inc.
- Quinochalcone compound and uses thereof for treating cancer or inflammation27 Apr 2021US 10,988,429 B2Life-Garden Biotech
- Treatment of pervasive developmental disorders with redox-active therapeutics11 Aug 2020US 10,736,857 B2PTC Therapeutics, Inc.
- Method for storing reduced coenzyme q1013 Mar 2025US 2025/0082585 A1Kaneka Corporation
- Compositions and methods for the prevention and/or treatment of mitochondrial disease, including friedreich's ataxia5 Dec 2024US 2024/0400588 A1Stealth BioTherapeutics Inc.
- Cannabis species as industrial chemical feedstocks23 Mar 2023US 2023/0085692 A1
- Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers24 Feb 2022US 2022/0055975 A1PTC Therapeutics, Inc.
- Compositions and methods for the prevention and/or treatment of mitochondrial disease, including friedreich's ataxia14 Oct 2021US 2021/0317146 A1Stealth BioTherapeutics Inc.
Most cited
By later US patents
- Tail variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers49US 7,432,305 B2Edison Pharmaceuticals, Inc. · 2008
- Treatment of pervasive developmental disorders with redox-active therapeutics47US 8,314,153 B2Edison Pharmaceuticals, Inc. · 2012
- Quinone compounds and their use in suppressing the production of SRS-A in mammals39US 4,393,075 ATakeda Chemical Industries, Ltd. · 1983
- Treatment of pervasive developmental disorders with redox-active therapeutics31US 8,653,144 B2Edison Pharmaceuticals, Inc. · 2014
- Quinone derivatives, their production and use22US 5,180,742 ATakeda Chemical Industries, Ltd. · 1993